Document is current
Any future updates will be listed below
-
Authors
Stanley, Daphne A
Honko, Anna N
Asiedu, Clement
Trefry, John C
Lau-Kilby, Annie W
Johnson, Joshua C
Hensley, Lisa
Ammendola, Virginia
Abbate, Adele
Grazioli, Fabiana
Foulds, Kathryn E
Cheng, Cheng
Wang, Lingshu
Donaldson, Mitzi M
Colloca, Stefano
Folgori, Antonella
Roederer, Mario https://orcid.org/0000-0001-7448-7040
Nabel, Gary J
Mascola, John
Nicosia, Alfredo
Cortese, Riccardo
Koup, Richard A
Sullivan, Nancy J
- License Information
-
More Information
Article History
Received: 18 August 2014
Accepted: 2 September 2014
First Online: 7 September 2014
Competing interests
: N.J.S., G.J.N., S.C., A.F., A.N. and R.C. claim intellectual property on gene-based vaccines for ebolavirus. S. C. and A.N. are named inventors in patents issued in the US Patent and Trademark Office and European, Australian, Chinese, Indian,and Japanese Patent Offices, and pending in the Canadian and Hong Kong Patent Offices, on chimpanzee adenovirus 3 (ChAd3). S. C., A.N, V.A. and R.C. are named inventors in a patent application with patents pending with the US Patent and Trademark Office and European Patent Office on filovirus vaccine.
